Childhood Cancer Data Initiative Annual Symposium (Abstract Registration): Submission #49

Submission information
Submission Number: 49
Submission ID: 150163
Submission UUID: 00ff31d9-3589-498a-b979-857e4e6d4e2e

Created: Thu, 08/28/2025 - 17:00
Completed: Thu, 08/28/2025 - 17:03
Changed: Thu, 08/28/2025 - 17:03

Remote IP address: 10.208.28.90
Submitted by: Anonymous
Language: English

Is draft: No
Abstract Submission for Poster Presentation
-------------------------------------------
Abstract Title:: AttentionAML: Accurate Molecular Categorization of Pediatric Acute Myeloid Leukemia by an Attention-Based Deep Learning Framework
Abstract::
As an aggressive hematopoietic malignancy, acute myeloid leukemia (AML) is defined by aberrant clonal expansion of abnormal myeloid progenitor cells, typically leading to bone marrow failure and compromised hematopoiesis. Characterized by morphological, molecular, and genetic alterations, pediatric AML encompasses multiple distinct subtypes that would exhibit subtype-specific responses to treatment and prognosis, underscoring the critical need of accurately identifying AML subtypes for effective clinical management and tailored therapeutic approaches. Traditional wet lab approaches such as immunophenotyping, cytogenetic analysis, morphological analysis, or molecular profiling to identify AML subtypes are labor-intensive, costly, and time-consuming. To address these challenges, we propose AttentionAML, a novel attention-based deep learning framework for accurately categorizing AML subtypes based on transcriptomic data from the Childhood Cancer Data Initiative (CCDI) system. Benchmarking tests based on 1,661 AML patients suggested that AttentionAML outperformed state-of-the-art methods across all evaluated metrics (accuracy: 0.96, precision: 0.96, recall of 0.96, F1-score: 0.96, and Matthews correlation coefficient: 0.96). Furthermore, we also demonstrated the superiority of AttentionAML over conventional approaches in terms of AML patient clustering visualization and subtype-specific gene marker characterization. We believe AttentionAML will bring remarkable positive impacts on downstream AML risk stratification and personalized treatment design. To enhance its impact, a user-friendly Python package implementing AttentionAML is publicly available at our lab's Github repository at https://github.com/wan-mlab/AttentionAML.

Abstract:: {Empty}
Authors::
1. First Name: Lusheng
   Last Name: Li
   Organization: University of Nebraska Medical Center
2. First Name: Joseph
   Middle Initial: D
   Last Name: Khoury
   Degree(s): M.D.
   Organization: University of Nebraska Medical Center
3. First Name: Jieqiong
   Last Name: Wang
   Degree(s): Ph.D.
   Organization: University of Nebraska Medical Center
4. First Name: Shibiao
   Last Name: Wan
   Degree(s): Ph.D.
   Organization: University of Nebraska Medical Center

Presenting Author:: Shibiao Wan
Institution:: University of Nebraska Medical Center
Email Address:: swan@unmc.edu